Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 18:40 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableRecruitingINTERVENTIONAL

HRS-AKI Treatment With TIPS in Patients With Cirrhosis

ClinicalTrials.gov · NCT05346393 · Registry updated: 2024-11-18

Condition / research focus: Cirrhosis, Liver; Hepatorenal Syndrome; Acute Kidney Injury; Ascites Hepatic
Sponsor: Jena University Hospital
Countries with listed sites: Germany
Registry dates and results: Start: 2022-11-29. Completion: 2026-06 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

TIPS (procedure)
Standard of Care (drug) — also listed as: Terlipressin + Albumin

Where the study takes place — 14 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

University Hospital RWTH Aachen
Aachen, Germany
Site recruitment: Recruiting
Charité - Universitätsmedizin Berlin CVK
Berlin, Germany
Site recruitment: Not yet recruiting
University Hospital Dresden, Medical Clinic I, Gastroenterology
Dresden, Germany
Site recruitment: Recruiting
Universitätsklinikum Essen (AöR)
Essen, Germany
Site recruitment: Not yet recruiting
University Hospital Freiburg
Freiburg im Breisgau, Germany
Site recruitment: Recruiting
University Hospital Halle
Halle, Germany
Site recruitment: Recruiting
University Hospital Hamburg-Eppendorf
Hamburg, Germany
Site recruitment: Recruiting
Medical University Hannover
Hanover, Germany
Site recruitment: Recruiting
Jena University Hospital, Clinic for Inner Medicine IV
Jena, Germany
Site recruitment: Recruiting
Klinikum Landshut AdöR der Stadt Landshut
Landshut, Germany
Site recruitment: Not yet recruiting
University Hospital Leipzig
Leipzig, Germany
Site recruitment: Not yet recruiting
RKH Clinic Ludwigsburg
Ludwigsburg, Germany
Site recruitment: Recruiting
Ludwig-Maximilians-University, Klinikum Großhadern
Munich, Germany
Site recruitment: Recruiting
University Hospital Münster, Medical Clinic B
Münster, Germany
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Use of Vasopressin Following the Fontan Operation

ClinicalTrials.gov · NCT02975999 · Registry updated: 2024-10-24

Condition / research focus: Pleural Effusion; Single-ventricle
Sponsor: Wake Forest University Health Sciences
Countries with listed sites: United States
Registry dates and results: Start: 2016-12. Completion: 2019-12 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug) — also listed as: Vasostrict, arginine
Normal Saline (drug) — also listed as: Placebo

Where the study takes place — 1 listed sites

Advocate Children's Hospital
Oak Lawn, Illinois, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE)

ClinicalTrials.gov · NCT04460560 · Registry updated: 2024-10-09

Condition / research focus: Hepatorenal Syndrome
Sponsor: University of Pennsylvania
Countries with listed sites: United States
Registry dates and results: Start: 2020-12-11. Completion: 2023-12-27 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin (drug)

Where the study takes place — 7 listed sites

California Pacific Medical Center
San Francisco, California, United States
Site recruitment: Not reported
Piedmont Healthcare, Inc
Atlanta, Georgia, United States
Site recruitment: Not reported
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Site recruitment: Not reported
Mayo Clinic
Rochester, Minnesota, United States
Site recruitment: Not reported
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Site recruitment: Not reported
Baylor Scott and White All Saints Medical Center
Fort Worth, Texas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Nasal Desmopressin Versus Topical Epinephrine in Endonasal Dacryocystorhinostomy

ClinicalTrials.gov · NCT05507476 · Registry updated: 2024-10-01

Condition / research focus: Anesthesia
Sponsor: Zagazig University
Countries with listed sites: Egypt
Registry dates and results: Start: 2022-09-01. Completion: 2023-06-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin Acetate Nasal, 10 μg/0.1 ml per spray (drug) — also listed as: Minirin 10 μg/0.1 ml per spray
Epinephrine topical 1:100,000 Nasal Packs (drug) — also listed as: Adrenaline 1 mg / 1ml

Where the study takes place — 1 listed sites

Zagazig university hospital
Zagazig, Al-Sharkia, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Safety and Efficacy of Continuous Infusion of Terlipressin With Norepinephrine Versus Norepinephrine Alone in Improving Outcomes of Acute Kidney Injury in Acute on Chronic Liver Failure With Septic Shock

ClinicalTrials.gov · NCT06556472 · Registry updated: 2024-08-16

Condition / research focus: Acute on Chronic Liver Failure
Sponsor: Institute of Liver and Biliary Sciences, India
Countries with listed sites: India
Registry dates and results: Start: 2024-08-15. Completion: 2025-08-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin (drug)
Norephrine (drug)

Where the study takes place — 1 listed sites

Institute of Liver & Biliary Sciences (ILBS)
New Delhi, National Capital Territory of Delhi, India
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Copeptin Kinetics in Critically Ill Patients With Posterior Reversible Encephalopathy Syndrome

ClinicalTrials.gov · NCT04950270 · Registry updated: 2024-07-22

Condition / research focus: Posterior Reversible Encephalopathy Syndrome
Sponsor: University Hospital, Tours
Countries with listed sites: France
Registry dates and results: Start: 2022-06-18. Completion: 2024-02-26 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Blood copeptin monitoring (biological)
phone interview (other)

Where the study takes place — 4 listed sites

University hospital
Nantes, France
Site recruitment: Not reported
Hospital
Orléans, France
Site recruitment: Not reported
University hospital
Rennes, France
Site recruitment: Not reported
University hospital
Tours, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Registry of Patients in Shock Treated With Vasopressin

ClinicalTrials.gov · NCT06422975 · Registry updated: 2024-07-15

Condition / research focus: Vasopressin Causing Adverse Effects in Therapeutic Use; Shock; Vasopressor Adverse Reaction; Vasopressin Deficiency
Sponsor: Hospital Universitario 12 de Octubre
Countries with listed sites: Spain
Registry dates and results: Start: 2024-07-09. Completion: 2026-06 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug)

Where the study takes place — 24 listed sites

Hospital Universitario de A Coruña
A Coruña, Spain
Site recruitment: Not yet recruiting
Hospital Universitario de Cruces
Barakaldo, Spain
Site recruitment: Not yet recruiting
Hospital de Sant Pau
Barcelona, Spain
Site recruitment: Not yet recruiting
Hospital del Mar
Barcelona, Spain
Site recruitment: Not yet recruiting
Hospital Universitario Valle de Hebrón
Barcelona, Spain
Site recruitment: Not yet recruiting
Hospital Universitario de Basurto
Bilbao, Spain
Site recruitment: Not yet recruiting
Hospital de Donostia
Donostia / San Sebastian, Spain
Site recruitment: Not yet recruiting
Hospital General Universitario de Elche
Elche, Spain
Site recruitment: Not yet recruiting
Hospital Universitario de Cabueñes
Gijón, Spain
Site recruitment: Not yet recruiting
Complejo Asistencial Universitario de León
León, Spain
Site recruitment: Not yet recruiting
Hospital Lucus Augustus
Lugo, Spain
Site recruitment: Recruiting
Hospital General Universitario Gregorio Marañón
Madrid, Spain
Site recruitment: Not yet recruiting
Hospital Universitario 12 de Octubre
Madrid, Spain
Site recruitment: Recruiting
Hospital Universitario La Princesa
Madrid, Spain
Site recruitment: Not yet recruiting
Hospital Universitario Ramón y Cajal
Madrid, Spain
Site recruitment: Not yet recruiting
Hospital Universitario Puerta de Hierro Majadahonda
Majadahonda, Spain
Site recruitment: Not yet recruiting
Complexo Hospitalario Universitario de Ourense
Ourense, Spain
Site recruitment: Not yet recruiting
Hospital Universitario Central de Asturias
Oviedo, Spain
Site recruitment: Not yet recruiting
Hospital Universitario Nuestra Señora de Candelaria
Santa Cruz de Tenerife, Spain
Site recruitment: Not yet recruiting
Hospital Universitario Marqués de Valdecilla
Santander, Spain
Site recruitment: Not yet recruiting
Hospital Clínico Universitario de Santiago
Santiago de Compostela, Spain
Site recruitment: Not yet recruiting
Hospital Universitario Joan XXIII
Tarragona, Spain
Site recruitment: Not yet recruiting
Hospital Clínico Universitario de Valencia
Valencia, Spain
Site recruitment: Not yet recruiting
Hospital Universitari i Politècnic La Fe
Valencia, Spain
Site recruitment: Not yet recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableNot yet recruitingOBSERVATIONAL

Saline Infusion Test in Hyponatremia

ClinicalTrials.gov · NCT06498856 · Registry updated: 2024-07-12

Condition / research focus: Hyponatremia
Sponsor: University Hospital, Akershus
Countries with listed sites: No country reported
Registry dates and results: Start: 2024-07. Completion: 2028-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Isotonic saline infusion (other)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Using Haemostatic Tourniquets:

ClinicalTrials.gov · NCT05242783 · Registry updated: 2024-06-25

Condition / research focus: Myoma
Sponsor: Wael Elbanna Clinic
Countries with listed sites: Egypt
Registry dates and results: Start: 2022-02-01. Completion: 2024-06-20 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin (drug) — also listed as: carbitocin, saline (placebo)

Where the study takes place — 1 listed sites

Wael El-Banna Clinic
Maadi, Cairo Governorate, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

The Effect of Intracapsular Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations

ClinicalTrials.gov · NCT05170230 · Registry updated: 2024-06-25

Condition / research focus: Myoma
Sponsor: Wael Elbanna Clinic
Countries with listed sites: Egypt
Registry dates and results: Start: 2022-02-27. Completion: 2026-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin (drug) — also listed as: carbitocin

Where the study takes place — 1 listed sites

Wael El Banna Clinic
Maadi, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

The Effect of Intramyometrial Injection of Terlipressin Versus Intramyometrial Injection of Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations

ClinicalTrials.gov · NCT05154279 · Registry updated: 2024-06-25

Condition / research focus: Laparoscopic Myomectomy
Sponsor: Wael Elbanna Clinic
Countries with listed sites: Egypt
Registry dates and results: Start: 2022-02-27. Completion: 2026-03-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin (drug) — also listed as: carbitocin, saline

Where the study takes place — 2 listed sites

National Research center
Cairo, Egypt
Site recruitment: Recruiting
Wael El Banna Clinic
Maadi, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic Shock

ClinicalTrials.gov · NCT06471231 · Registry updated: 2024-06-24

Condition / research focus: Septic Shock; Renal Function Replacement
Sponsor: Azienda Usl di Bologna
Countries with listed sites: Italy
Registry dates and results: Start: 2024-05-15. Completion: 2026-05-15 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

vasopressin infusion when the norepinephrine dosage is equal to or greater than 0.25 mcg/kg/min (drug)
vasopressin infusion when the norepinephrine dosage is equal to or greater than 0.5 mcg/kg/min (drug)

Where the study takes place — 1 listed sites

Azienda Unità Sanitaria Locale
Bologna, Italy
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4TerminatedINTERVENTIONAL

Desmopressin for Bedwetting in Children With SCD

ClinicalTrials.gov · NCT04420585 · Registry updated: 2024-05-07

Condition / research focus: Nocturnal Enuresis; Anemia, Sickle Cell
Sponsor: Montefiore Medical Center
Countries with listed sites: United States
Registry dates and results: Start: 2020-07-07. Completion: 2023-06-12 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug) — also listed as: DDAVP

Where the study takes place — 1 listed sites

Children's Hospital at Montefiore
The Bronx, New York, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Desmopressin Monotherapy for Monosymptomatic Nocturnal Enuresis

ClinicalTrials.gov · NCT06285006 · Registry updated: 2024-04-23

Condition / research focus: Nocturnal Enuresis
Sponsor: Al-Azhar University
Countries with listed sites: Egypt
Registry dates and results: Start: 2024-02-23. Completion: 2024-05-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug)

Where the study takes place — 1 listed sites

Alazhar university
Asyut, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Shock and Acute Conditions OutcOmes Platform

ClinicalTrials.gov · NCT06376318 · Registry updated: 2024-04-19

Condition / research focus: Circulatory Shock; Sepsis; Cardiogenic Shock; Major Trauma; Surgical Shock
Sponsor: Saint-Louis Hospital, Paris, France
Countries with listed sites: Canada
Registry dates and results: Start: 2024-01-01. Completion: 2026-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Inotrope (drug) — also listed as: Vasopressor
Mechanical circulatory support (device)
anti-bodies (drug)

Where the study takes place — 1 listed sites

St Michael's Hospital
Toronto, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Oral Vasopressin Modulates Neural Responses to Looming Visual Stimuli: An Eye-tracking Study

ClinicalTrials.gov · NCT06329063 · Registry updated: 2024-04-11

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2024-03-05. Completion: 2025-07-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug) — also listed as: Antidiuretic Hormone
Placebo (drug) — also listed as: Placebo treatment

Where the study takes place — 1 listed sites

University of Electronic Science and Technology of China
Chengdu, Sichuan, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

The Effects of Oral Vasopressin on Attention Control: An Eye-tracking Study

ClinicalTrials.gov · NCT06329037 · Registry updated: 2024-04-11

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2024-03-05. Completion: 2025-07-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug) — also listed as: Antidiuretic Hormone
Placebo (drug) — also listed as: Placebo treatment

Where the study takes place — 1 listed sites

University of Electronic Science and Technology of China
Chengdu, Sichuan, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Low Dose Vasopressin vs Phenylephrine in Cardiac Surgery

ClinicalTrials.gov · NCT04602767 · Registry updated: 2024-03-29

Condition / research focus: Acute Kidney Injury
Sponsor: Thomas Jefferson University
Countries with listed sites: United States
Registry dates and results: Start: 2020-10-15. Completion: 2024-10-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug) — also listed as: Pitressin
Phenylephrine (drug) — also listed as: Neosynephrine

Where the study takes place — 1 listed sites

Thomas Jefferson Univesity
Philadelphia, Pennsylvania, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

A SAD/MAD Study of Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Volunteers

ClinicalTrials.gov · NCT04103034 · Registry updated: 2024-03-18

Condition / research focus: Cerebrovascular Stroke; Large-Artery Atherosclerosis (Embolus/Thrombosis); Intracranial Arteriosclerosis
Sponsor: Band Therapeutics
Countries with listed sites: Austria
Registry dates and results: Start: 2019-10-07. Completion: 2020-09-14 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

BT200 (drug)
Desmopressin (drug) — also listed as: MINIRIN® Injection
Placebo (drug)

Where the study takes place — 1 listed sites

Medical University of Vienna
Vienna, Austria
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4WithdrawnINTERVENTIONAL

Angiotensin II vs. Vasopressin in Septic Shock

ClinicalTrials.gov · NCT05193370 · Registry updated: 2024-03-15

Condition / research focus: Septic Shock
Sponsor: University of New Mexico
Countries with listed sites: United States
Registry dates and results: Start: 2022-01-03. Completion: 2022-11-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Angiotensin II (drug) — also listed as: Giapreza
Vasopressin (drug) — also listed as: Vasostrict

Where the study takes place — 1 listed sites

University of New Mexico Health Sciences Center
Albuquerque, New Mexico, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 18:40 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableRecruitingINTERVENTIONAL

HRS-AKI Treatment With TIPS in Patients With Cirrhosis

ClinicalTrials.gov · NCT05346393 · Registry updated: 2024-11-18

Condition / research focus: Cirrhosis, Liver; Hepatorenal Syndrome; Acute Kidney Injury; Ascites Hepatic
Sponsor: Jena University Hospital
Countries with listed sites: Germany
Registry dates and results: Start: 2022-11-29. Completion: 2026-06 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

TIPS (procedure)
Standard of Care (drug) — also listed as: Terlipressin + Albumin

Where the study takes place — 14 listed sites

University Hospital RWTH Aachen
Aachen, Germany
Site recruitment: Recruiting
Charité - Universitätsmedizin Berlin CVK
Berlin, Germany
Site recruitment: Not yet recruiting
University Hospital Dresden, Medical Clinic I, Gastroenterology
Dresden, Germany
Site recruitment: Recruiting
Universitätsklinikum Essen (AöR)
Essen, Germany
Site recruitment: Not yet recruiting
University Hospital Freiburg
Freiburg im Breisgau, Germany
Site recruitment: Recruiting
University Hospital Halle
Halle, Germany
Site recruitment: Recruiting
University Hospital Hamburg-Eppendorf
Hamburg, Germany
Site recruitment: Recruiting
Medical University Hannover
Hanover, Germany
Site recruitment: Recruiting
Jena University Hospital, Clinic for Inner Medicine IV
Jena, Germany
Site recruitment: Recruiting
Klinikum Landshut AdöR der Stadt Landshut
Landshut, Germany
Site recruitment: Not yet recruiting
University Hospital Leipzig
Leipzig, Germany
Site recruitment: Not yet recruiting
RKH Clinic Ludwigsburg
Ludwigsburg, Germany
Site recruitment: Recruiting
Ludwig-Maximilians-University, Klinikum Großhadern
Munich, Germany
Site recruitment: Recruiting
University Hospital Münster, Medical Clinic B
Münster, Germany
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Use of Vasopressin Following the Fontan Operation

ClinicalTrials.gov · NCT02975999 · Registry updated: 2024-10-24

Condition / research focus: Pleural Effusion; Single-ventricle
Sponsor: Wake Forest University Health Sciences
Countries with listed sites: United States
Registry dates and results: Start: 2016-12. Completion: 2019-12 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug) — also listed as: Vasostrict, arginine
Normal Saline (drug) — also listed as: Placebo

Where the study takes place — 1 listed sites

Advocate Children's Hospital
Oak Lawn, Illinois, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE)

ClinicalTrials.gov · NCT04460560 · Registry updated: 2024-10-09

Condition / research focus: Hepatorenal Syndrome
Sponsor: University of Pennsylvania
Countries with listed sites: United States
Registry dates and results: Start: 2020-12-11. Completion: 2023-12-27 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin (drug)

Where the study takes place — 7 listed sites

California Pacific Medical Center
San Francisco, California, United States
Site recruitment: Not reported
Piedmont Healthcare, Inc
Atlanta, Georgia, United States
Site recruitment: Not reported
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Site recruitment: Not reported
Mayo Clinic
Rochester, Minnesota, United States
Site recruitment: Not reported
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Site recruitment: Not reported
Baylor Scott and White All Saints Medical Center
Fort Worth, Texas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Nasal Desmopressin Versus Topical Epinephrine in Endonasal Dacryocystorhinostomy

ClinicalTrials.gov · NCT05507476 · Registry updated: 2024-10-01

Condition / research focus: Anesthesia
Sponsor: Zagazig University
Countries with listed sites: Egypt
Registry dates and results: Start: 2022-09-01. Completion: 2023-06-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin Acetate Nasal, 10 μg/0.1 ml per spray (drug) — also listed as: Minirin 10 μg/0.1 ml per spray
Epinephrine topical 1:100,000 Nasal Packs (drug) — also listed as: Adrenaline 1 mg / 1ml

Where the study takes place — 1 listed sites

Zagazig university hospital
Zagazig, Al-Sharkia, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Safety and Efficacy of Continuous Infusion of Terlipressin With Norepinephrine Versus Norepinephrine Alone in Improving Outcomes of Acute Kidney Injury in Acute on Chronic Liver Failure With Septic Shock

ClinicalTrials.gov · NCT06556472 · Registry updated: 2024-08-16

Condition / research focus: Acute on Chronic Liver Failure
Sponsor: Institute of Liver and Biliary Sciences, India
Countries with listed sites: India
Registry dates and results: Start: 2024-08-15. Completion: 2025-08-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin (drug)
Norephrine (drug)

Where the study takes place — 1 listed sites

Institute of Liver & Biliary Sciences (ILBS)
New Delhi, National Capital Territory of Delhi, India
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Copeptin Kinetics in Critically Ill Patients With Posterior Reversible Encephalopathy Syndrome

ClinicalTrials.gov · NCT04950270 · Registry updated: 2024-07-22

Condition / research focus: Posterior Reversible Encephalopathy Syndrome
Sponsor: University Hospital, Tours
Countries with listed sites: France
Registry dates and results: Start: 2022-06-18. Completion: 2024-02-26 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Blood copeptin monitoring (biological)
phone interview (other)

Where the study takes place — 4 listed sites

University hospital
Nantes, France
Site recruitment: Not reported
Hospital
Orléans, France
Site recruitment: Not reported
University hospital
Rennes, France
Site recruitment: Not reported
University hospital
Tours, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Registry of Patients in Shock Treated With Vasopressin

ClinicalTrials.gov · NCT06422975 · Registry updated: 2024-07-15

Condition / research focus: Vasopressin Causing Adverse Effects in Therapeutic Use; Shock; Vasopressor Adverse Reaction; Vasopressin Deficiency
Sponsor: Hospital Universitario 12 de Octubre
Countries with listed sites: Spain
Registry dates and results: Start: 2024-07-09. Completion: 2026-06 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug)

Where the study takes place — 24 listed sites

Hospital Universitario de A Coruña
A Coruña, Spain
Site recruitment: Not yet recruiting
Hospital Universitario de Cruces
Barakaldo, Spain
Site recruitment: Not yet recruiting
Hospital de Sant Pau
Barcelona, Spain
Site recruitment: Not yet recruiting
Hospital del Mar
Barcelona, Spain
Site recruitment: Not yet recruiting
Hospital Universitario Valle de Hebrón
Barcelona, Spain
Site recruitment: Not yet recruiting
Hospital Universitario de Basurto
Bilbao, Spain
Site recruitment: Not yet recruiting
Hospital de Donostia
Donostia / San Sebastian, Spain
Site recruitment: Not yet recruiting
Hospital General Universitario de Elche
Elche, Spain
Site recruitment: Not yet recruiting
Hospital Universitario de Cabueñes
Gijón, Spain
Site recruitment: Not yet recruiting
Complejo Asistencial Universitario de León
León, Spain
Site recruitment: Not yet recruiting
Hospital Lucus Augustus
Lugo, Spain
Site recruitment: Recruiting
Hospital General Universitario Gregorio Marañón
Madrid, Spain
Site recruitment: Not yet recruiting
Hospital Universitario 12 de Octubre
Madrid, Spain
Site recruitment: Recruiting
Hospital Universitario La Princesa
Madrid, Spain
Site recruitment: Not yet recruiting
Hospital Universitario Ramón y Cajal
Madrid, Spain
Site recruitment: Not yet recruiting
Hospital Universitario Puerta de Hierro Majadahonda
Majadahonda, Spain
Site recruitment: Not yet recruiting
Complexo Hospitalario Universitario de Ourense
Ourense, Spain
Site recruitment: Not yet recruiting
Hospital Universitario Central de Asturias
Oviedo, Spain
Site recruitment: Not yet recruiting
Hospital Universitario Nuestra Señora de Candelaria
Santa Cruz de Tenerife, Spain
Site recruitment: Not yet recruiting
Hospital Universitario Marqués de Valdecilla
Santander, Spain
Site recruitment: Not yet recruiting
Hospital Clínico Universitario de Santiago
Santiago de Compostela, Spain
Site recruitment: Not yet recruiting
Hospital Universitario Joan XXIII
Tarragona, Spain
Site recruitment: Not yet recruiting
Hospital Clínico Universitario de Valencia
Valencia, Spain
Site recruitment: Not yet recruiting
Hospital Universitari i Politècnic La Fe
Valencia, Spain
Site recruitment: Not yet recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableNot yet recruitingOBSERVATIONAL

Saline Infusion Test in Hyponatremia

ClinicalTrials.gov · NCT06498856 · Registry updated: 2024-07-12

Condition / research focus: Hyponatremia
Sponsor: University Hospital, Akershus
Countries with listed sites: No country reported
Registry dates and results: Start: 2024-07. Completion: 2028-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Isotonic saline infusion (other)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Using Haemostatic Tourniquets:

ClinicalTrials.gov · NCT05242783 · Registry updated: 2024-06-25

Condition / research focus: Myoma
Sponsor: Wael Elbanna Clinic
Countries with listed sites: Egypt
Registry dates and results: Start: 2022-02-01. Completion: 2024-06-20 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin (drug) — also listed as: carbitocin, saline (placebo)

Where the study takes place — 1 listed sites

Wael El-Banna Clinic
Maadi, Cairo Governorate, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

The Effect of Intracapsular Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations

ClinicalTrials.gov · NCT05170230 · Registry updated: 2024-06-25

Condition / research focus: Myoma
Sponsor: Wael Elbanna Clinic
Countries with listed sites: Egypt
Registry dates and results: Start: 2022-02-27. Completion: 2026-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin (drug) — also listed as: carbitocin

Where the study takes place — 1 listed sites

Wael El Banna Clinic
Maadi, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

The Effect of Intramyometrial Injection of Terlipressin Versus Intramyometrial Injection of Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations

ClinicalTrials.gov · NCT05154279 · Registry updated: 2024-06-25

Condition / research focus: Laparoscopic Myomectomy
Sponsor: Wael Elbanna Clinic
Countries with listed sites: Egypt
Registry dates and results: Start: 2022-02-27. Completion: 2026-03-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin (drug) — also listed as: carbitocin, saline

Where the study takes place — 2 listed sites

National Research center
Cairo, Egypt
Site recruitment: Recruiting
Wael El Banna Clinic
Maadi, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic Shock

ClinicalTrials.gov · NCT06471231 · Registry updated: 2024-06-24

Condition / research focus: Septic Shock; Renal Function Replacement
Sponsor: Azienda Usl di Bologna
Countries with listed sites: Italy
Registry dates and results: Start: 2024-05-15. Completion: 2026-05-15 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

vasopressin infusion when the norepinephrine dosage is equal to or greater than 0.25 mcg/kg/min (drug)
vasopressin infusion when the norepinephrine dosage is equal to or greater than 0.5 mcg/kg/min (drug)

Where the study takes place — 1 listed sites

Azienda Unità Sanitaria Locale
Bologna, Italy
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4TerminatedINTERVENTIONAL

Desmopressin for Bedwetting in Children With SCD

ClinicalTrials.gov · NCT04420585 · Registry updated: 2024-05-07

Condition / research focus: Nocturnal Enuresis; Anemia, Sickle Cell
Sponsor: Montefiore Medical Center
Countries with listed sites: United States
Registry dates and results: Start: 2020-07-07. Completion: 2023-06-12 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug) — also listed as: DDAVP

Where the study takes place — 1 listed sites

Children's Hospital at Montefiore
The Bronx, New York, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Desmopressin Monotherapy for Monosymptomatic Nocturnal Enuresis

ClinicalTrials.gov · NCT06285006 · Registry updated: 2024-04-23

Condition / research focus: Nocturnal Enuresis
Sponsor: Al-Azhar University
Countries with listed sites: Egypt
Registry dates and results: Start: 2024-02-23. Completion: 2024-05-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug)

Where the study takes place — 1 listed sites

Alazhar university
Asyut, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Shock and Acute Conditions OutcOmes Platform

ClinicalTrials.gov · NCT06376318 · Registry updated: 2024-04-19

Condition / research focus: Circulatory Shock; Sepsis; Cardiogenic Shock; Major Trauma; Surgical Shock
Sponsor: Saint-Louis Hospital, Paris, France
Countries with listed sites: Canada
Registry dates and results: Start: 2024-01-01. Completion: 2026-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Inotrope (drug) — also listed as: Vasopressor
Mechanical circulatory support (device)
anti-bodies (drug)

Where the study takes place — 1 listed sites

St Michael's Hospital
Toronto, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Oral Vasopressin Modulates Neural Responses to Looming Visual Stimuli: An Eye-tracking Study

ClinicalTrials.gov · NCT06329063 · Registry updated: 2024-04-11

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2024-03-05. Completion: 2025-07-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug) — also listed as: Antidiuretic Hormone
Placebo (drug) — also listed as: Placebo treatment

Where the study takes place — 1 listed sites

University of Electronic Science and Technology of China
Chengdu, Sichuan, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

The Effects of Oral Vasopressin on Attention Control: An Eye-tracking Study

ClinicalTrials.gov · NCT06329037 · Registry updated: 2024-04-11

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2024-03-05. Completion: 2025-07-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug) — also listed as: Antidiuretic Hormone
Placebo (drug) — also listed as: Placebo treatment

Where the study takes place — 1 listed sites

University of Electronic Science and Technology of China
Chengdu, Sichuan, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Low Dose Vasopressin vs Phenylephrine in Cardiac Surgery

ClinicalTrials.gov · NCT04602767 · Registry updated: 2024-03-29

Condition / research focus: Acute Kidney Injury
Sponsor: Thomas Jefferson University
Countries with listed sites: United States
Registry dates and results: Start: 2020-10-15. Completion: 2024-10-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug) — also listed as: Pitressin
Phenylephrine (drug) — also listed as: Neosynephrine

Where the study takes place — 1 listed sites

Thomas Jefferson Univesity
Philadelphia, Pennsylvania, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

A SAD/MAD Study of Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Volunteers

ClinicalTrials.gov · NCT04103034 · Registry updated: 2024-03-18

Condition / research focus: Cerebrovascular Stroke; Large-Artery Atherosclerosis (Embolus/Thrombosis); Intracranial Arteriosclerosis
Sponsor: Band Therapeutics
Countries with listed sites: Austria
Registry dates and results: Start: 2019-10-07. Completion: 2020-09-14 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

BT200 (drug)
Desmopressin (drug) — also listed as: MINIRIN® Injection
Placebo (drug)

Where the study takes place — 1 listed sites

Medical University of Vienna
Vienna, Austria
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4WithdrawnINTERVENTIONAL

Angiotensin II vs. Vasopressin in Septic Shock

ClinicalTrials.gov · NCT05193370 · Registry updated: 2024-03-15

Condition / research focus: Septic Shock
Sponsor: University of New Mexico
Countries with listed sites: United States
Registry dates and results: Start: 2022-01-03. Completion: 2022-11-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Angiotensin II (drug) — also listed as: Giapreza
Vasopressin (drug) — also listed as: Vasostrict

Where the study takes place — 1 listed sites

University of New Mexico Health Sciences Center
Albuquerque, New Mexico, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →